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ABSTRACT: Neurological disorders are commonly reported among veterans who returned from the Gulf war. Veterans who suffer from Gulf War
illness (GWI) complain of continued symptom persistence that includes neurological disorders, muscle weakness, headaches, and memory
loss, that developed during or shortly after the war. Our recent research showed that chemical exposure associated microbial dysbiosis accompanied by a leaky gut connected the pathologies in the intestine, liver, and brain. However, the mechanisms that caused the symptoms to persist
even 30 years after the war remained elusive to investigators. In this study, we used a rodent model of GWI to investigate the persistence of
microbiome alterations, resultant chronic inflammation, and its effect on neurotrophic and synaptic plasticity marker BDNF. The results showed
that exposure to GW chemicals (the pesticide permethrin and prophylactic drug pyridostigmine bromide) resulted in persistent pathology
characterized by the low relative abundance of the probiotic bacteria Akkermansia muciniphila in the gut, which correlated with high circulatory
HMGB1 levels, blood-brain barrier dysfunction, neuroinflammation and lowered neurotrophin BDNF levels. Mechanistically, we used mice lacking the NLRP3 gene to investigate this inflammasome’s role in observed pathology. These mice had significantly decreased inflammation and
a subsequent increase in BDNF in the frontal cortex. This suggests that a persistently low species abundance of Akkermansia muciniphila and
associated chronic inflammation due to inflammasome activation might be playing a significant role in contributing to chronic neurological problems in GWI. A therapeutic approach with various small molecules that can target both the restoration of a healthy microbiome and decreasing
inflammasome activation might have better outcomes in treating GWI symptom persistence.
Keywords: Dysbiosis, Akkermansia muciniphila, BDNF, RAGE, 3-nitrotyrosine, peroxynitrite, inflammasomes, NLRP3
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Introduction

Neurological disorders are commonly reported among veterans
who returned from the Gulf war (GW) of 1990-1991.1-3
Afflicted veterans complain of problems including neuralgias,
migraine headaches, muscle weakness and coordination, and
memory problems.2,4,5 These issues occur in combination with
other Gulf War illness (GWI) symptoms, and their pathology
is not very well understood. Most veterans who suffer from
GWI developed their symptoms during or shortly after the
war, and these symptoms persist 30 years later. Although the
causes of these symptoms are difficult to pinpoint, epidemiological studies have established a compelling link between
these symptoms in different GW veteran cohorts and
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environmental exposures which occurred during the war, or
chemicals that were applied to the warriors before or shortly
after the war.6-8 Such exposures include dust from desert
storms, depleted uranium, combustion byproducts from oil
wells, possible chemical weapons, pesticides, vaccines, and prophylactic medicines such as pyridostigmine bromide (PB).9-12
In recent years, research has focused on studying symptoms as
well as elucidating mechanisms of these disorders, using GW
veteran cohorts as well as animals and in vitro studies. For example, Van Riper et al13 reported widespread disruption in white
matter microstructure distribution across brain regions involved
in the processing and modulating chronic pain. James et al found
that there was a significant positive correlation between
C-reactive protein (CRP), pain, and neurocognitive mood in
GW veterans. Another study by Abou-Donia et al14 reported
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elevated autoantibodies to neurons and other brain cells, eg, tau
proteins, glial acidic fibrillary protein (GFAP), and myosin basic
protein (MBP) which indicate neuronal injury or gliosis in GW
veterans. In other recent animal studies, Zakirova et al15 found
cognitive deficits in mice several weeks after treatment with GW
chemicals, and these deficits were associated with increased
astrogliosis and a reduction in synaptophysin in mouse hippocampi and cerebral cortex. Furthermore, Madhu et al16 found
that cognitive impairments which persisted 10 months postexposure to GW chemicals were associated with increased density of activated microglia and astrocytes in rats and inflammation
with elevated levels of HMGB1 in the cerebral cortex.
These studies provide evidence that exposure to GW chemicals plays a significant role in the persistence of neurological dysfunction. This may generally be through the disruption of
neuronal networks, reactive glia, which fuel inflammation or
weak neuronal growth and neuroplasticity. Many neurological
disorders such as Parkinson’s disease (PD), Alzheimer’s disease
(AD), bipolar disorders, and neuropathic pain17-21 are associated
with decreased levels of neurotrophins or impairments in their
signaling pathways.22,23 These disorders also commonly present
with chronic neuroinflammation.24-26 Brain-derived neurotropic
factor (BDNF) is the most prevalent neurotrophins in the brain
and has been very widely studied in several diseases and brain
functions.23,27 It is produced by neurons, and it plays crucial
functions in neuroplasticity, growth, and survival of neurons.28
To date, our previous research has focused mainly on the
possible role of an altered microbiome (bacteriome and virome)
in contributing to a persistent inflammatory phenotype, in
acute models of GWI.29-32 We proposed that exposure to GW
chemicals alters the microbiome in rodents, which then drives
inflammation through the production of immunostimulatory
particles, ie, damage-associated molecular pattern (DAMPS)
and pathogen-associated molecular patterns (PAMPS). These
DAMPS may then continuously trigger inflammation in different organ systems. Although our results largely supported
our hypothesis, we were still limited in knowing whether the
observed changes and mechanisms in the microbiome and
associated chronic inflammation due to an altered microbiome
indeed persisted.
In this present study, we used a persistence rodent model of
GWI in which mice were exposed to GW chemicals for 2
weeks (representing the war phase) after which no further GW
chemicals were applied for the next 20 weeks (to represent
20 years after the war). We then investigated the persistence of
microbiome alterations, chronic inflammation, and its effect on
neuronal health (BDNF levels). We further used an NLRP3
KO mouse to study its potential role of this inflammasome as a
primary contributor to the observed neuroinflammation.

Materials and Methods
Materials
We purchased PB and permethrin from Sigma-Aldrich
(St. Louis, MO). Anti-RAGE, anti-Claudin 5, anti-HMGB1,

anti-IL-1β, and anti-ASC-2 were purchased from Santacruz
Biotechnology (Dallas, TX), Anti-BDNF from cell signaling
technology (Danvers, MA), while anti-NLRP3, anti-3-nitrotyrosine, anti-IL-6, anti-IL-18, anti-TMEM 119 primary
antibodies were purchased from Abcam (Cambridge, MA).
Species specific biotinylated conjugated secondary antibodies
and Streptavidin-HRP (Vectastain Elite ABC kit) were purchased from Vector Laboratories (Burlingame, CA).
Fluorescence conjugated (Alexa Fluor) secondary antibodies,
ProLong Diamond antifade mounting media with DAPI and
Pierce LAL chromogenic endotoxin quantitation kit were
bought from Thermo Fisher Scientific (Waltham, MA) while
enzyme-linked immunosorbent assay (ELISA) kits were purchased from ProteinTech (Rosemond, IL). Unless otherwise
specified, all other chemicals used were purchased from Sigma.
Paraffin-embedding of tissue and sectioning were done by
AML laboratories (Baltimore, MD) and at the Instrument
Resources Facility, University of South Carolina School of
medicine (Columbia, SC). Microbiome analysis was done by
Cosmos ID (Rockville, MD).

Animal experiments
Adult (10 weeks old) wild type male (C57BL/6J mice) and
NLRP3 deficient adult (10 weeks) male (B6N.129Nlrp3tm3Hhf/J) mice were purchased from the Jackson
Laboratories (Bar Harbor, ME). Mice experiments were
implemented in accordance with National Institutes of Health
(NIH) guidelines for humane care and use of laboratory animals and local Institutional Animal Care and Use Committee
(IACUC) standards. All procedures were approved by the
University of South Carolina at Columbia, SC. Mice were
housed individually and fed on a chow diet at 22°C to 24°C
with a 12 h light/12 h dark cycle. All mice were sacrificed after
animal experiments had been completed. Right after anesthesia, blood from the mice was drawn using cardiac puncture, to
preserve serum for further experimentation. Their brains were
removed immediately, and the frontal cortex dissected out and
was fixed using Bouin’s fixative solution. We also collected the
fecal pellets and luminal contents for microbiome analysis.

Treatments and rodent model of Gulf War illness
Mice were exposed to GW chemicals (PB and permethrin)
based on established rodent models of GWI with some modifications.31,33-35 The treated mice group (GWP) and NLRP3KO
(GWP-NLRP3KO) mice group were dosed tri-weekly for 2
weeks with PB (2 mg/kg) and permethrin (200 mg/kg) by oral
gavage, after which no further treatments with GW chemicals
were applied, and mice were fed on a normal chow diet for
20 weeks. The control group (CONT) of mice received vehicle
(0.6% dimethyl sulfoxide in phosphate-buffered saline [PBS])
by oral gavage as in other experiments above. Each group had a
starting sample size of n = 6 until the end of the experiments.
All experimental mice had an average starting weight of
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26.5 grams and a final weight of 33.5 grams at the end of the
study. There was no signifcant difference of weight difference
between controls and Gulf War chemical treated groups over
the 20 week period.

Microbiome analysis
Microbiome analysis was done by CosmosID (Rockville, MD,
USA) from fecal pellets and luminal contents, which were collected from the animals of each group after sacrifice. DNA
isolation, sequencing, and analysis of gut microbiome were
performed according to vendor optimized protocol. Briefly,
DNA was isolated from fecal samples using the
ZymoBIOMICS Miniprep kit, following the manufacturer’s
instructions. 16S sequencing was carried out on the V3V4 (341
nt–805 nt) region of the 16S ribosomal RNA (rRNA) gene
with a 2-step polymerase chain reaction (PCR) strategy. First,
PCR was performed using 16S-optimized primer set to
amplify the V3–V4 regions of 16S ribosomal DNA (rDNA)
within the metagenomic DNA. Then the PCR products from
the previous steps were mixed at equal proportions and used as
templates in the second step to produce Illumina dual-index
libraries for sequencing, with both adapters containing an 8bp
index allowing for multiplexing. The dual-indexed library
amplification products are purified using Ampure beads
(Beckman Coulter). Library quantification was performed
using Qubit dsDNA HS assay (Thermo Fisher) and qualified
on a 2100 Bioanalyzer instrument (Agilent) to show a distribution with a peak in the expected range. A final qualitative PCR
(qPCR) quantification was performed before loading onto a
MiSeq (Illumina) sequencer for PE250 (v2 chemistry). The
sequences for each sample were then run on the 16S pipeline of
the CosmosID GENIUS software, and results were analyzed.

Laboratory Methods
Immunohistochemistry
The fixed brain tissues were embedded in paraffin and sliced into
5 μM thick sections. These sections were deparaffinized following optimized standard protocols. Epitope retrieval solution and
steamer (IHC-Word, Woodstock, MD) were used for epitope
retrieval for deparaffinized sections. About 3% H2O2 was used
for the recommended time to block the endogenous peroxidase.
After serum blocking, the primary antibodies were applied at recommended and optimized concentrations. Species-specific biotinylated conjugated secondary antibodies and streptavidin
conjugated with HRP were used to implement antigen-specific
immunohistochemistry. 3,3'-Diaminobenzidine (DAB) (Sigma
Aldrich, St Louis, MD) was used as a chromogenic substrate.
Mayer’s hematoxylin solution (Sigma Aldrich) was used as a
counterstain. Sections were washed between steps using PBS
1×. Finally, stained sections were mounted in Simpo-mount
(GBI Laboratories, Mukilteo, WA). Tissue sections were
observed using Olympus BX63 microscope (Olympus, America).
Cellsens software from Olympus America (Center Valley, PA)
was used for morphometric analysis of images.
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Table 1. Primer sequences.
Primer

Sequence

mm-Claudin 5

Sense: TTCGCCAACATTGTCGTCC
Antisense: TCTTCTTGTCGTAGTCGCCG

mm-18 S

Sense: TTCGAACGAACGTCTGCCCTATCAA
Antisense: ATGGTAGGCACGGCGATA

Immunofluorescence staining
Paraffin-embedded sections were deparaffinized using the
standard protocol. Epitope retrieval solution and steamer were
used for epitope retrieval of sections. Primary antibodies were
used at recommended dilutions. Species-specific secondary
antibodies conjugated with Alexa Fluor (633-red and 488green) were used at advised dilution. In the end, the stained
sections were mounted using prolong diamond antifade reagent with DAPI. Sections were observed under Olympus fluorescence microscope BX63 using 20X, 40X, 60X objective lens.

Real-time quantitative PCR
Total RNA was isolated from frontal cortex tissue homogenization in TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions and purified with
the use of RNeasy mini kit columns (Qiagen, Valencia, CA,
USA). Complementary DNA (cDNA) was synthesized from
purified RNA (1 µg) using iScript cDNA synthesis kit (Biorad, Hercules, CA, USA) following the manufacturer’s standard protocol. Real-time qPCR (qRTPCR) was performed with
the gene-specific primers using Sso Advanced SYBR Green
Supermix and CFX96 thermal cycler (Bio-rad, Hercules, CA,
USA). Threshold cycle (Ct) values for the selected genes were
normalized against respective samples internal control 18S.
Each reaction was carried out in triplicates for each gene and
for each sample. The relative fold change was calculated by the
2−∆∆Ct method. The sequences for the primers used for realtime PCR are provided in Table 1.

Endotoxin level detection by Litmus Amebocyte
Lysate assay
Serum bacterial endotoxin levels (EU/mL) were detected using
the Pierce LAL Chromogenic Endotoxin Quantification Kit
(Waltham, MA) according to the manufacturer’s instructions.
Briefly, serum samples were obtained from mice and diluted
1:80 with endotoxin-free water. The endotoxins were then
quantified.

Western blot analysis
About 30 mg of tissue from each brain tissue sample was immediately homogenized in 300 μL of RIPA buffer with protease
and phosphatase inhibitors cocktail (Pierce, Rockford, IL) using
slow speed mechanical homogenizer. The homogenate was centrifuged, and the supernatant was collected and saved for
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experimental use. About 30 μg of denatured protein from each
sample was loaded per well of Novex 4% to 12% bis-tris gradient gel (Life Technologies, Carlsbad, CA) and subjected for
standard sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Separated protein bands were transferred
to nitrocellulose membrane using precut nitrocellulose/filter
paper sandwiches (Bio-Rad, Hercules, CA) and Trans-Blot
Turbo transfer system (Bio-Rad) using 30-minute transfer protocol. Furthermore, blots were blocked with 3% bovine serum
albumin solution prepared in Tris-buffered saline with 0.05%
tween-20 (TBS-T). Primary antibodies were used at recommended dilutions in 1.5% blocking buffer and incubated overnight at 4°C. Species-specific anti-IgG secondary antibody
conjugated with HRP were used at recommended dilutions in
1% blocking buffer and incubated for 2 h at room temperature.
Pierce ECL Western Blotting substrate (Thermo Fisher
Scientific Inc, Rockford, IL) was used in dark to develop the
blot. Finally, the blot was imaged using G:Box Chemi XX6
(Syngene imaging systems) and subjected to densitometry analysis using Image J software.

chronic diseases of the gut, metabolic reprogramming, and
neuronal deficiencies. We analyzed 10 distinct bacterial species
that had a fold change difference in abundance and has been
found to contribute to inflammation and metabolic responses
(Figure 1A) We found that mice treated with GW chemicals
(GWP) had a significantly lower abundance of A muciniphila
(significant, Figure 1B, *P = .008; n = 5), Bacteroides thetaiotomicron, and Dorea Sp (not significant) when compared with mice
treated with only vehicle control (Figure 1A). Notably, A
muciniphila has been associated with several health benefits.36-38
Furthermore, we found that mice which were treated with GW
chemicals (GWP) had significantly higher HMGB1 levels in
their serum compared with mice treated with vehicle control
only (CONT) *P = .034; n = 6 (Figure 1C and D). We then carried out statistical analyses to determine whether the increased
levels of HMGB1 were related to the observed decreased relative abundance of A muciniphila. In Figure 1E, we found that
there was a negative correlation between A muciniphila abundance and circulatory HMGB1 levels (Pearson’s r = −0.50;
R2 COD = 0.255).

ELISA

Exposure to GW chemicals is associated with bloodbrain barrier tight junction protein dysregulation,
and the changes persist five months after exposure

Serum IL-1β, IL-6, and TNF-α were estimated using ELISA
kits from ProteinTech (Rosemont, IL) according to manufacturer protocol.

Statistical analysis
We conducted calculations for each experimental condition
prior to initiation of the study. Preliminary data confirmed that
the sample size was enough to achieve a minimum statistical
power of 0.80 at an alpha of 0.05. One-way analysis of variance
(ANOVA) was used with post hoc comparisons among different exposure conditions or treatments (eg, least significant differences [LSD] and Bonferroni correction) to compare means
among multiple groups. Student t tests was used to compare
means between two groups at the termination of treatment.
Correlative associations were tested using Pearson’s correlation
coefficient analysis with Graph pad prism software (GraphPad
Software Inc, La Jolla, CA). A p value of less than p=0.05 was
considered statistically significant.

Results
Gulf War chemical exposure results in a decreased
relative abundance of Akkermansia muciniphila,
which negatively correlates with increased
circulatory HMGB1 levels
Our previous studies have strongly suggested that exposure to
GW chemicals alters the microbiome and these alterations
may contribute to the persistence of GWI symptoms through
the release of DAMPs and PAMPs.30-32 In this study, we analyzed the microbiome for alterations in specific bacterial species that have a notable role in inflammation persistence in

The study by Abou-Donia et al14 suggests the presence of a
leaky blood-brain barrier (BBB) among veterans who returned
from the GW, and this may be a portal for immunostimulatory
particles such as DAMPS and PAMPS to continuously fuel
neuroinflammation. We studied the messenger RNA (mRNA)
and protein expression levels of Claudin 5, the major tight
junction protein in the complex that makes up the BBB. We
found that GWP mice also exhibited significantly lower
Claudin 5 mRNA and protein levels compared with vehicle
control treated mice (CONT) P = .042 and P = .03; n = 6
(Figure 2A to C). Furthermore, we studied the levels of
Claudin 5 in the BBB by observing colocalizations between
Claudin 5 and CD31, a marker for endothelial cells that make
up the lining of the blood vessels (Figure 2D and E). We found
that there was a significant decrease in the number of colocalizations (yellow spots) constituting Claudin 5 and CD31 in
GWP mice compared with controls (CONT) (P = .04; n = 6).
This result points to the fact that at least one major component of BBB integrity is repressed at the protein level, paving
the way for possible dysfunctional BBB, and this may lead to
the passage of DAMPS such as HMGB1 leaking into the
brain and triggering several immune responses.

GW chemical exposure is associated with persistent
activation of microglia via the HMGB1-RAGE
pathway resulting in increased reactive oxygen
species and triggering of the NLRP3 inflammasome
Chronic neurological disorders such as AD and PD are characterized by activation of immune cells such as microglia, the
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Figure 1. Exposure to GW chemicals results in decreased relative abundance of Akkermansia muciniphila and chronic high levels of circulatory HMGB1.
(A) Percentage abundance of gut bacteria species. Percentage abundance of 10 most abundant species in the gut bacteriome are represented comparing
GW chemical treated groups (GWP) to vehicle control treated group groups (CONT). Data are represented as the mean of 6 mice per group. (B)
Percentage relative abundance of A muciniphila. Percentage relative abundance was determined from duplicate fecal samples of 5 mice per group
treated with GW chemicals (GWP) compared with mice treated with vehicle control only (CONT). Data are represented as mean ± SEM (*P < .05; n = 5).
(C) Serum HMGB1 levels. Western blot of HMGB1 levels in serum for mice treated with GW chemicals (GWP) compared with mice treated with vehicle
control (CONT) only. Data are represented as mean ± SEM. (D) Densitometry of HMGB1 immunoblots, normalized against Ponceau red (*P < .05; n = 6).
(E) Relationship between A muciniphila and circulatory HMGB1 levels. A correlative analysis was carried out to determine how A muciniphila is related to
serum HMGB1 levels. We found a negative correlation between A muciniphila and serum HMGB1 levels (Pearson’s r = −0.50; R 2 COD = 0.255 shaded
area represents 95% confidence bands). GW indicates Gulf War; SEM, standard error of the mean; COD, coefficient of dipersion.
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Figure 2. Exposure to GW chemicals is associated with altered Claudin 5 levels in the frontal cortex. (A) Claudin 5 mRNA levels in the frontal cortex:
mRNA levels of Claudin 5 as studied by RTqPCR show that mice exposed to GW chemicals (GWP) had significantly decreased Claudin 5 mRNA levels
compared with mice treated with vehicle control only (CONT). (B) Claudin 5 protein levels in frontal cortex. Western blot analysis of Claudin 5 protein
levels in CONT and GWP treated mice. (C) Morphometry analysis of Claudin 5 immunoblots, normalized against β-actin (*P < .05; n = 6). Data are
represented as mean ± SEM. (D) Representative immunofluorescence micrographs of the blood-brain barrier showing colocalization of tight junction
protein Claudin 5 (labeled in red) and endothelial cell marker CD31 (labeled in green) as yellow spots around a BBB (magnification 60× and scale bar
10 µm) and DAPI stained nucleus (labeled in blue). See Supplemental Figure S2 for images of separate channels. Inset (magnification 40× and scale bar
20 µm) shows the whole micrograph field, from which the main image was obtained. (E) Quantitative morphometry analysis of colocalizations for every
100 cells represented as % ROI (*P < .05; n = 6). Data are represented as mean ± SEM. BBB indicates blood-brain barrier; GW, Gulf War; SEM, standard
error of the mean; ROI, region of interest.

resident macrophages of the brain.39 These cells may be
activated by the presence of pathogens or DAMPS, such
as HMGB1. We studied the protein expression levels of activated microglia marker TMEM119. The results showed that
there was a significant increase in activated microglia in the
frontal cortex of mice treated with GW chemicals (GWP)
compared with controls (CONT) (*P = .02; n = 6) (Figure 3A
and B) even after 3 months of exposure. Furthermore, we found

that there was evidence of activated HMGB1-RAGE signaling, as indicated by colocalization events. Figure 3C and D
shows a significantly high expression of RAGE protein levels
(*P = .04; n = 6) and subsequent increased RAGE-HMGB1
colocalizations (*P = .001; n = 6) in GWP mice compared with
controls (Figure 3E and F). RAGE is a receptor, which binds
several ligands including HMGB1. Interaction of HMGB1RAGE can lead to increasing reactive oxygen species (ROS)

Kimono et al

0.6
0.5

D
CONT

GWP

45kDa

RAGE

42kDa

β-actin

E
CONT GWP

*

0.4
0.3
0.2
0.1
0.0

C

CONT

GWP

3.0

*

2.5
2.0
1.5
1.0
0.5
0.0

F

0.9

HMGB1/RAGE Colocalization
Events/100 cells (% ROI)

HMGB1(Red)
RAGE(Green)

0.7

TMEM119 Morphometry
(% ROI)

GWP

CONT

B

Normalized expression of RAGE
(x -actin, arbitrary units)

TMEM 119

A

7

0.8
0.7

CONT

GWP

*

0.6
0.5
0.4
0.3
0.2
0.1
0.0

CONT

GWP

Figure 3. Activation of macrophages and associated HMGB1/RAGE complex formation. (A) TMEM119 immunoreactivity in frontal cortex. Representative
immunohistochemistry micrographs of TMEM 119 reactivity in control (CONT) and GW chemical treated (GWP) mice (magnification 40× and scale bar
50 µm). (B) Morphometric analysis (represented as % ROI) obtained from 10 to 15 images from different microscopy fields from each mouse sample. Data are
represented as mean ± SEM (*P < .05; n = 6). (C) Western blots of RAGE protein levels in the frontal cortex of GWP and CONT treated mice. (D) Morphometry
analysis of all immunoblots normalized against β-actin (n = 5) (*P < .05; n = 6). Data are represented as mean ± SEM. (E) RAGE/HMGB1 complex formation.
HMGB1 (labeled in red) and RAGE (labeled in green) and DAPI stained nucleus (labeled in blue) in GWP and CONT mice. Colocalizations are shown as
yellow dots and marked with arrows in the micrographs (magnification 40× and scale bar 20 µm). See Supplemental Figure S3 for images of separate
channels. (F) Morphometric analysis (represented as % ROI) obtained from 6 to 8 images from different microscopy fields from each mouse sample. Data are
represented as mean ± SEM. (*P < .05; n = 6). GW indicates Gulf War; SEM, standard error of the mean; ROI, region of interest.

generation, eg, peroxynitrite, which reacts with tyrosine in proteins to form the stable adduct 3 nitrotyrosine. In Figure 4A
and B, we detected significantly higher levels 3-nitrotyrosine
(3NT) in GW chemical treated mice (GWP) compared with
vehicle control treated mice (CONT); (*P = .01; n = 6). We also
found that mice exposed to GW chemicals had significantly
higher inflammasome activation compared with vehicle control treated mice (CONT) Figure 4C and D (*P < .001; n = 6).
This activation was detected as yellow dots indicating a colocalization between the NLRP3 protein complex (labeled with
red antibody) and the adapter protein ASC2 (marked with
green), which facilitate the processing of pro-inflammatory

cytokines from their basal inactive to more active form via protein cleavage.

Exposure to GW chemicals, decreased abundance
of A muciniphila is associated with a persistently
increased neuroinflammation and low levels of
BDNF
Inflammasomes are large immune complexes found in several
cell types and are responsible for processing the inflammatory
cytokines IL-1β and IL-18 by cleaving them from their precursors.40 Uncontrolled activation of these complexes can lead
to chronic inflammation, as has been found in cancer, diabetes,
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and neurodegenerative disease.41-44 In our study, we found that
NLRP3 inflammasome activation was also significantly associated with increased IL-1β (Figure 5A and B; P = .001, n = 6),
IL-18 (Figure 5C and D; P = .021, n = 6), and IL-6 (Figure 5E
and F; P = .01, n = 6) protein levels in GWP mouse frontal cortex when compared with mice treated with only vehicle control
(CONT) (Figure 5A and F). Neurodegenerative diseases are
often characterized by neuroinflammation, accompanied by
decreased levels of neurotrophins.18,45 Similarly, in this study,
we observed that mice which were treated with GW chemicals
had significantly lower levels of the neurotrophin BDNF when
compared with mice treated with only vehicle control (CONT)
(Figure 5G and H, P = .018 and Figure 5I and J, P = .001 n = 6).

A muciniphila relative abundance correlates with
BDNF levels and persistent neuroinflammation
A high abundance of A muciniphila has been linked to decreased
inflammation in chronic diseases.38,46,47 To study whether the
host bacteria’s abundance played a role in affecting chronic
inflammation and sustained BDNF levels in our model of
GWI, we carried out correlative analyses to determine whether

there were statistically significant relationships between the
bacterial abundance, inflammation, and BDNF levels. The
results showed that there was a significant positive correlation
between BDNF levels and abundance of A muciniphila
(Pearson’s r = 0.83, R2 COD = 0.73; P = .0024), and a significant
negative correlation with IL-1β protein levels (Pearson’s
r = −0.684; R2 COD = 0.46; P = .02) (Figure 6A and B). Shaded
area represents 95% confidence bands.

Deletion of NLRP3 is protective against persistent
systemic and neuroinflammation and is associated
with an increase in BDNF levels
To study the role of NLRP3 in driving inflammation and lowering BDNF levels, we treated mice lacking NLRP3 with GW
chemicals and then subjected them to our experimental conditions for 20 weeks or 5 months. We then studied the protein
levels of IL-1β, IL-18, IL-6, and BDNF by western blot
analysis and immunohistochemistry. Our results show that
there were significantly lower levels of IL-1β (Figure 7A
and E; P = .006, n = 6, IL-18 (Figure 7B and F; P = .01, n = 6),
IL-6 (Figure 7C and G; P = .015, n = 6), and increased BDNF
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(Figure 7D and H; P = .007, and Figure 7I and J; P = .017, n = 6)
levels in the frontal cortex of NLRP3 KO mice treated with
GW chemicals (GWP-NLRP3KO), when compared with wild
type mice treated with GW chemicals (GWP). Furthermore,
we studied systemic inflammation levels in the three groups of
mice by analyzing serum IL-1β (Figure 8A; P = .046, n = 6),
TNF-α (Figure 8B; P = .032, n = 6) and IL-6 (Figure 8C;
P = .042, n = 6) levels using an ELISA. Our results show that
there is significantly lower inflammation in NLRP3KO mice
treated with GW chemicals (GWP-NLRP3KO) compared
with mice treated with GW chemicals (GWP).

Discussion

In our previous studies, we reported that there was a general
alteration in microbiome accompanied by endotoxemia, a leaky
gut, and inflammation in different organs such as the small
intestine, brain, and liver.30-32 We found significant increases in
phyla Firmicutes and Tenericutes over Bacteriodetes in GW
chemical exposed mice when compared with controls.31
However, it was not clear whether these alterations persisted
long after GW chemical exposure or would eventually resolve
over time through the repopulation and reconstitution of the
host microbiome. We also were eager to study the mechanisms
that would connect the altered microbiome and the persistent
inflammatory changes in the intestine and the neural-immune
network. In this study, mice were exposed to the GW chemicals and allowed to ad libitum diet and water for 20 weeks. This
was to simulate the period of exposure (during the GW) and
the subsequent period following their return from the war. We
found that exposure to GW chemicals (the pesticide permethrin and prophylactic drug PB) in mice resulted in persistent
pathology characterized by the low abundance of A muciniphila, high circulatory HMGB1 levels, BBB dysfunction,

neuroinflammation, and lowered neurotrophin BDNF levels.
Our findings and the proposed mechanism are summarized as
a schematic illustration in Figure 9.
We report that exposure to GW chemicals caused a decrease
in A muciniphila or resulted in conditions that favor other bacteria populations repopulate over A muciniphila (Figure 1A).
A muciniphila is a mucin degrading bacterium which exists as
part of the normal human gut flora and is abundant in healthy
individuals.47-50 In recent years, the herein reported bacterium
is emerging as an important probiotic which can be consumed
to improve health.51 This bacterium was found to improve
ulcerative colitis in mice52 and restored colonic mucus layer
thickness with decreased inflammation in aging mice.53 In
another study, the abundance of this bacterium inversely correlated with inflammation and altered lipid metabolism in
obese mice.51 Although the mechanism by which A muciniphila
promotes these health benefits is not fully understood, studies
report that the bacterium strengthens gut barrier integrity
through its association with enterocytes and also produces high
amounts of anti-inflammatory cytokine IL-8.48,54 It is possible
that the low levels of this bacterium in the gut compromised
gut barrier integrity, a condition that we have observed in our
previous acute models of GWI.29,31 This condition of compromised gut barrier integrity has also been reported among veterans who suffer from gastrointestinal problems in GWI.55
Moreover, a recent study by Janulewicz et al56 showed that GWI
afflicted veterans with gastrointestinal disturbances present
gut dysbiosis among bacteria of the phylum Verrucomicrobia.
Interestingly, A muciniphila belongs to the same phylum.
Another study found that A muciniphila treatment normalized
diet-induced metabolic endotoxemia, adiposity, and the adipose
tissue marker CD11c in obese mice, which otherwise had
increased inflammatory indicators in the intestine and aided in
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the metabolic disease development.46 Similarly, our studies of
GWI mouse models have consistently found that altered levels
of tight junction proteins in the gut was associated with increase
in endotoxins and DAMPs such as HMGB1 and inflammation that was related to an alteration of gut microbiome
abundance.29,32 Notably, mice in the present study (using a
persistence model of GWI) that were exposed to similar
chemicals showed a slight increase in serum endotoxin levels
(low-level endotoxemia consistent with an obesity phenotype)
in GW chemical treated mice when compared with vehicle
control treated mice (Supplemental Figure S1). In addition, a
significant increase in circulatory HMGB1 levels was observed
in GW chemical exposed mice which negatively correlated
with A muciniphila relative abundance (Figure 1C to E) suggesting that a sustained and consistent low inflammatory trigger was closely associated with a persistent change in the
microbiome and decreased A Muciniphila abundance in these
mice. Furthermore, the persistence of systemic inflammatory
indicators such as pro-inflammatory cytokines, eg, IL-1β, IL-6,
and TNF-α (Figure 8A to C), endotoxin levels and serum
HMGB1 for such a long period that failed to ease even 20 weeks
after exposure (equivalent to > 20 human years) and its connection with an altered microbiome triggered our interest to study
their effects on neuronal structures and their networks.
Before we could study the neuroinflammatory indicators for
persistence, we needed to assess the integrity of the BBB, a vital
interface of neuronal physiology and pathology. Interestingly,
our results showed that the expression of Claudin 5, a critical
tight junction protein of the BBB in the brain, was decreased in
the frontal cortex of mice treated with GW chemicals compared with controls (Figure 2A to E). This protein, together
with others such as Claudin 1, zona occludens, and occludins
make up tight junctions in the BBB. The BBB is a selective
barrier found at the interface of blood vessels in the brain and
brain tissue. It is made of a single cell layer of endothelial cells,
astrocyte, and pericytes. Its unique properties allow it to tightly

regulate the movement of particles between the circulation and
brain tissue.57,58 Claudin 5 and other tight junction proteins are
found between adjacent endothelial cells of blood vessels and
help to anchor these cells to create a tightly regulated selective
barrier that allows the passage of particles between the blood
and the brain.59 Low levels of this protein have been found in
neurodegenerative and neuroinflammatory diseases such as
AD, PD, and schizophrenia.60,61 We found decreased mRNA
and protein levels of this protein in GWP mice compared with
controls (Figure 2A to E). This provides strong evidence that
at least one key component of the BBB is dysregulated and this
possibly compromised the barrier’s integrity, likely caused by
the serum mediators endotoxins, HMGB1, and pro-inflammatory cytokines causing it to become leaky. However, we have no
direct evidence of such an event in an in vitro experimental
setup using BBB endothelial cells. We hypothesized that this
leaky BBB allowed the passage of unwanted particles such as
DAMPs and PAMPS, HMGB1, as one such example, which
we found to be greatly increased in the serum. It is also worth
noting that even though serum endotoxin levels are not significantly higher in GWP mice compared with controls, even low
levels of endotoxins over a long time can be a toxic stimulus to
the body and may contribute to observed pathology.62,63
HMGB1 is a DAMP known to trigger proinflammatory
pathways through toll-like receptors (TLRs), eg, TLR4, and
through the receptor for advanced glycation end products
(RAGE).64,65 We found that there was increased activation of
microglia in GWP mice compared with controls (Figure 3A
and B) with an increased expression of RAGE receptors in the
frontal cortex (Figure 3C and D). We also detected HMGB1/
RAGE complex formation using immunofluorescence microscopy, which may indicate activation of RAGE signaling (Figure
3E and F). The activation of this pathway is known to result in
the transcription of pro-inflammatory cytokines and the generation of ROS66 such as nitric oxide. High levels of nitric oxide
in the presence of superoxide could result in the formation of
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peroxynitrite, a potent ROS which attacks tyrosine to form 3
nitrotyrosine denaturing them and rendering them dysfunctional. We found significantly higher levels of ROS in our
GWP mice compared with controls (Figure 4A and B).
High amounts of ROS are a known trigger of the NLRP3
inflammasome.67 Inflammasomes are large protein complexes
that are assembled in response to infections, etc, and are involved
in the processing of pro-inflammatory cytokines such as IL-1β
and IL-18. We found that mice treated with GW chemicals
had higher expression of NLRP3/ASC2 complex formation
compared with controls (Figure 4C and D). Although inflammasomes are triggered as a defense mechanism, chronic activation of these complexes has been implicated in conditions
characterized by chronic low-grade inflammation such as diabetes, PD, and ALS.68,69 This activation of the NLRP3 inflammasomes was followed by increased IL-1β and IL-18 levels in
the brain (Figure 5A to D), which might contribute to the persistent neuroinflammation in GWI.
In neurological diseases, inflammation has been associated
with poor neuronal health, with fewer neurons, decreased neuronal plasticity, and growth.70 This in part is due to low levels
of neurotrophins such as BDNF. BDNF is a neurotrophin produced by neurons and is involved in neuronal growth, survival,
and plasticity.23 Studies by Guan and Fang, and another by
Lapchak, suggest that increased IL-1β levels interfered with
BDNF synthesis,71,72 while Tong et al showed that increased
IL-1β interfered with BDNF signaling through the PI3K/
AKT pathway by preventing its activation of AKT. The above
mechanisms resulted in decreased growth and survival of neurons.73 In this study, we report low levels of BDNF in the frontal cortex of mice, which were treated with GW chemicals
compared with controls even 5 months post-exposure (Figure
5F and G). We also studied any correlations that BDNF, IL-1β
with A muciniphila relative abundance may have to connect the
intestinal, microbiome changes, and neuronal levels of these
mediators referenced above. In Figure 6A and B, we show that
A muciniphila relative abundance correlated negatively with
IL-1β levels and positively with BDNF levels. The above result
indicates that A muciniphila relative abundance might have
played a role in modulating neuroinflammation and neurotrophin levels in GWI as has been the case in obesity and other
diseases described previously.46 This could be through the bacterium’s production of anti-inflammatory compounds that
counter inflammation or modulation of the intestinal barrier
integrity. However, more studies need to be done to determine
the exact mechanism. Finally, to study the role of NLRP3
inflammasome in contributing to neuroinflammation that persists for a prolonged period and its association with increased
abundance of Akkermansia, we used a mouse model with the
systemic knockout of NLRP3 gene (KO mouse). The results
found that the deletion of this gene was associated with
increased BDNF levels and protected the mice from neuroinflammation (Figure 7A to J). Deleting NLRP3 is protective
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Figure 9. Schematic illustration of the proposed mechanism for
persistent neuroinflammatory pathology in current study.

through preventing inflammasome activation and subsequent
processing of pro-inflammatory cytokines and distinctly proves
that the persistent inflammation in GWI chemical exposed
mice that had altered A muciniphila abundance is due to
NLRP3-mediated inflammasome activation though there may
be multiple molecular mediators for triggering such an activation. Our current study identifies some of these mediators such
as gut-derived endotoxins, HMGB1, or peroxynitrite, to name
a few. Still, the molecular mechanism of such a trigger remains
speculative currently.
In conclusion, we report that persistence of GWI inflammatory symptoms is characterized by low relative abundance
of A muciniphila and chronic high circulatory HMGB1 levels
which trigger NLRP3 mediated neuroinflammation and
decreased levels of neurotrophins through RAGE signaling
as shown in Figure 9. These findings not only provide
insight into the mechanism of persistent neurological disturbances in GWI but also provide possible therapeutic targets. First, the microbiome can be targeted through
replacement or enhancing of A muciniphila gut bacterial
populations and other significantly lowered probiotic bacteria, and second, through therapies that target RAGE signaling or NLRP3 inflammasomes to relieve persistent
inflammation and improve quality of life of veterans who
suffer from GWI veterans.
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